Jiangsu GDK Biotechnology Co Ltd (688670) — Working Capital to Net Assets Ratio
Jiangsu GDK Biotechnology Co Ltd (688670) has a Working Capital to Net Assets ratio of 23.8% as of June 2025. Working capital of CN¥295.19 Million (current assets of CN¥501.95 Million minus current liabilities of CN¥206.76 Million) is measured against net assets of CN¥1.24 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See Jiangsu GDK Biotechnology Co Ltd net asset quality index to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Jiangsu GDK Biotechnology Co Ltd Working Capital to Net Assets (2017–2024)
This chart shows how Jiangsu GDK Biotechnology Co Ltd's Working Capital to Net Assets ratio has evolved across 8 annual periods from 2017 to 2024. As of June 2025, the ratio stands at 23.8%, reflecting working capital of CN¥295.19 Million against net assets of CN¥1.24 Billion CNY. Check Jiangsu GDK Biotechnology Co Ltd (688670) tangible net worth to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Jiangsu GDK Biotechnology Co Ltd (2017–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Jiangsu GDK Biotechnology Co Ltd from 2017 to 2024, covering 8 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Jiangsu GDK Biotechnology Co Ltd market capitalisation.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 29.1% | CN¥371.70 Million | CN¥1.28 Billion | CN¥582.58 Million | CN¥210.88 Million | ▼ -7.0 pp |
| 2023 | 36.1% | CN¥494.91 Million | CN¥1.37 Billion | CN¥722.24 Million | CN¥227.34 Million | ▼ -8.3 pp |
| 2022 | 44.4% | CN¥648.52 Million | CN¥1.46 Billion | CN¥951.02 Million | CN¥302.50 Million | ▼ -13.6 pp |
| 2021 | 58.0% | CN¥848.02 Million | CN¥1.46 Billion | CN¥1.07 Billion | CN¥221.68 Million | ▲ +52.4 pp |
| 2020 | 5.7% | CN¥13.71 Million | CN¥242.50 Million | CN¥522.79 Million | CN¥509.07 Million | ▼ -357.2 pp |
| 2019 | 362.8% | CN¥-393.22 Million | CN¥-108.38 Million | CN¥95.34 Million | CN¥488.56 Million | ▼ -51.0 pp |
| 2018 | 413.8% | CN¥-369.71 Million | CN¥-89.34 Million | CN¥13.17 Million | CN¥382.88 Million | ▼ -120.3 pp |
| 2017 | 534.1% | CN¥-327.57 Million | CN¥-61.33 Million | CN¥13.25 Million | CN¥340.82 Million | — |